Literature DB >> 21340917

Corneal assay for angiogenesis.

M Ziche1.   

Abstract

In order to develop angiogenic and antiangiogenic strategies, concerted efforts have been made to provide animal models for more quantitative analysis of in vivo angiogenesis. In vivo techniques consist of the cornea pocket and iris implant in the eye, the rabbit ear chamber, the dorsal skinfold chamber, the cranial window, the hamster cheek pouch window, the sponge implant assay, the fibrin clots, the sodium alginate beads and the Matrigel plugs, the rat mesenteric window, the chick embryo chorioallantoic membrane and the air sac in mice and rats (1). In this chapter we will discuss the avascular cornea assay, and the advantages and disadvantages of using this assay in different species. The cornea assay is based on the placement of an angiogenic inducer (tumor tissue, cell suspension, growth factor) into a corneal pocket in order to evoke vascular outgrowth from the peripherally located limbal vasculature. In comparison to other in vivo assays, this assay has the advantage of measuring only new blood vessels, because the cornea is initially avascular.

Entities:  

Year:  2001        PMID: 21340917     DOI: 10.1385/1-59259-143-4:131

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  3 in total

1.  A mouse model of the cornea pocket assay for angiogenesis study.

Authors:  Zhongshu Tang; Fan Zhang; Yang Li; Pachiappan Arjunan; Anil Kumar; Chunsik Lee; Xuri Li
Journal:  J Vis Exp       Date:  2011-08-18       Impact factor: 1.355

Review 2.  In vivo models of angiogenesis.

Authors:  K Norrby
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

3.  The Effects of Vaccinium myrtillus Extract on Hamster Pial Microcirculation during Hypoperfusion-Reperfusion Injury.

Authors:  Teresa Mastantuono; Noemy Starita; Daniela Sapio; Sabato Andrea D'Avanzo; Martina Di Maro; Espedita Muscariello; Marco Paterni; Antonio Colantuoni; Dominga Lapi
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.